Eli Lilly
Trade Eli Lilly 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About LLY
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies.
LLY Key Statistics
Stock Snapshot
With a market cap of 992.28B, Eli Lilly(LLY) trades at $1,047.00. The stock has a price-to-earnings ratio of 50.94 and currently yields dividends of 56.3%.
During the trading session on 2025-11-19, Eli Lilly(LLY) shares reached a daily high of $1,055.55 and a low of $1,026.25. At a current price of $1,047.00, the stock is +2.0% higher than the low and still -0.8% under the high.
Trading volume for Eli Lilly(LLY) stock has reached 3.57M, versus its average volume of 4.93M.
Over the past 52 weeks, Eli Lilly(LLY) stock has traded between a high of $1,055.55 and a low of $623.78.
Over the past 52 weeks, Eli Lilly(LLY) stock has traded between a high of $1,055.55 and a low of $623.78.
LLY News
Rumors are swirling that pharmaceutical company Eli Lilly (LLY) will be the next major company to split its stock. TipRanks Black Friday Sale Claim 60% off Ti...
Eli Lilly (LLY) stands out for its diversified pharmaceutical portfolio, robust pipeline, and strategic acquisitions that are fueling growth. LLY has strong te...
Don't wait for a stock split to buy the stock, though. Eli Lilly (LLY +1.03%) has had a tumultuous year. The pharmaceutical giant lagged the market for much of...
Analyst ratings
74%
of 31 ratingsMore LLY News
Truist analyst Srikripa Devarakonda raised the firm’s price target on Eli Lilly (LLY) to $1,182 from $1,038 and keeps a Buy rating on the shares. The firm is po...
(RTTNews) - Eli Lilly and Company (LLY) announced plans to open a new Lilly Gateway Labs site in Philadelphia. The new Gateway Labs site will occupy 44,000 squa...
Key Points Eli Lilly has advanced in the triple-digits over three years, thanks to its weight loss drug portfolio. The following two biotech companies, due to...
Eli Lilly shares rose again Tuesday, their sixth increase in the past seven sessions. The drugmaker's market cap also closed at a record, $973.8 billion, as Lil...
Mangoceuticals, Inc. recently announced the launch of MangoRx Direct and PeachesRx Direct programs, offering direct access to Eli Lilly's Zepbound and Novo Nord...
Eli Lilly’s weight-loss drug Zepbound is on track to be the world’s top-selling drug, and Lilly is inching closer to a $1 trillion market cap. Biopharma is bac...
Key Points Weight loss pills could account for 25% of the market share over the long term. The GLP-1 market is expected to grow to $100 billion by 2030. New...